Pyrone Compound Derivatives for Multiple Sclerosis Treatment
Solution Overview
Problem
Current treatments for multiple sclerosis (MS) are inadequate, as the disease remains incurable, and patients often require lifelong treatment with limited options for effectively managing symptoms and halting disease progression.
Innovation Solution
A pharmaceutical composition comprising a pyrone compound, specifically a compound of Formula I, combined with a pharmaceutically acceptable excipient, is administered to treat symptoms of inflammatory, neurodegenerative, or immune-mediated diseases such as MS.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for multiple sclerosis are used, then patients can manage symptoms to some extent, but the disease remains incurable and patients require lifelong treatment with limited options
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of known pyrone compounds to create novel derivatives with improved therapeutic properties. The invention systematically varies substituents at different positions on the pyrone ring structure to optimize both efficacy and versatility for treating multiple sclerosis and related conditions
Solution Approach 2:
The patent creates composite therapeutic solutions by combining pyrone compounds with pharmaceutically acceptable excipients to form pharmaceutical compositions. This composite approach enables the active compound to be delivered effectively while providing multiple administration options and improving overall treatment versatility
2Duration of action of stationary object
If lifelong treatment is required for MS patients, then continuous symptom management is possible, but treatment burden and complexity increase
Solution Approach 1:
The patent achieves universality by designing pyrone compound derivatives that can address multiple aspects of multiple sclerosis pathology simultaneously. The compounds are intended to provide both symptomatic relief and disease-modifying effects, reducing the need for multiple separate medications and simplifying the long-term treatment regimen
Data Source
AI summary
Provided herein are pharmaceutical compositions, each comprising a pyrone compound, for example, a compound of Formula I, and a pharmaceutically acceptable excipient. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of an inflammatory, neurodegenerative, or immune-mediated disease (e.g., multiple sclerosis).



